Cambridge researchers are developing implants to help repair brain pathways damaged by Parkinson’s disease. As part of a £69 ...

In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, ...

The company signed the agreement with Karolinska Institutet's Department of Cell and Molecular Biology professor Johan ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

The completion of the funding round follows Newronika’s recent receival of an IDE from the FDA for the Parkinson’s therapy ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

The results? Disappointing. "We found no evidence to support exenatide as a disease-modifying treatment for people with ...

The Oklahoma Medical Research Foundation has received a $3 million grant to study Parkinson's disease, potentially leading to ...

The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...

She was happily married, pregnant with her first child and had recently completed her residency in family medicine. Soon ...

Lars von Trier has been admitted to a care centre where he will receive treatment for Parkinson’s disease. The Danish filmmaker, 68, is known for his dark and provocative films including Dancer in the ...